Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The IsraelIRLCF -13.45%65 Debt-to-Equity is 1.25 as of Mar. 2026, which is 54% below its 10-year median of 2.72. GuruFocus rates IRLCF with a GF Score™ of 65/100 and a GF Value™ of $273.43. The stock has 5 warning signs investors should review. Among 1,422 Chemicals companies, The Israel ranks worse than 88.96% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for The Israel's Debt-to-Equity or its related term are showing as below:
IRLCF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 1.08 Med: 2.72 Max: 7.47
Current: 1.25
During the past 13 years, the highest Debt-to-Equity Ratio of The Israel was 7.47. The lowest was 1.08. And the median was 2.72.
IRLCF's Debt-to-Equity is ranked worse than 88.96% of 1422
companies
in the Chemicals industry
Industry Median: 0.36
vs IRLCF: 1.25
The Israel (OTCPK:IRLCF) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
The Israel Debt-to-Equity Related Terms
The Israel Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for The Israel's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, The Israel's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Israel Debt-to-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, The Israel's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where The Israel's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Israel (IRLCF) has a Debt-to-Equity of 1.25 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on The Israel and its competitors. This is 54% below median its historical median of 2.72. Over the past decade, The Israel's Debt-to-Equity has ranged from 1.08 to 7.47. According to the industry distribution chart, The Israel ranks #1265 out of 1422 companies in the Chemicals industry, placing it in the top 89%.
Is The Israel's Debt-to-Equity too high?
The Israel's current Debt-to-Equity of 1.25 is 54% below median its 10-year median of 2.72. Over the past 10 years, this metric has ranged from a low of 1.08 to a high of 7.47. The Chemicals industry median Debt-to-Equity is 0.36. The Israel's value of 1.25 is 247.2% above this industry median. Based on the distribution chart, The Israel ranks #1265 out of 1422 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, The Israel has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does The Israel's Debt-to-Equity compare to LIN and SHW?
According to the Chemicals industry distribution chart, The Israel ranks #1265 out of 1422 companies for Debt-to-Equity. This places The Israel in the lower half of its industry. The industry median Debt-to-Equity is 0.36. The Israel's value of 1.25 is 247.2% above this benchmark. Historically, The Israel's own Debt-to-Equity has ranged from 1.08 to 7.47 over the past decade. While the company's 10-year median is 2.72 vs. the industry median of 0.36, The Israel has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Chemicals company?
The median Debt-to-Equity among Chemicals companies is 0.36, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Israel's current Debt-to-Equity of 1.25 is 247.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on The Israel and its competitors. For the Chemicals industry, the median Debt-to-Equity is 0.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Israel's current Debt-to-Equity is 1.25, which is 54% below median its own 10-year median of 2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Israel stock overvalued right now?
The Israel (IRLCF) has a current Debt-to-Equity of 1.25. The stock's GF Value™ is $273.43, compared to a current price of $238.00 — trading 13% below its estimated fair value. The current Debt-to-Equity is 1.25, which is 54% below median its 10-year median of 2.72 and 247.2% above the Chemicals industry median of 0.36. The Israel's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For The Israel (IRLCF), the current Debt-to-Equity is 1.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Israel (IRLCF) Overvalued in 2026?
Based on GuruFocus' analysis, The Israel stock appears to be undervalued.
The current stock price of $238.00 is trading 13% below its estimated GF Value™ of $273.43.
Key valuation signals for IRLCF:
Debt-to-Equity: 1.25 (54% below median its 10-year median of 2.72)
GF Value™: $273.43 vs. price of $238.00 (13% below fair value)
Industry Position: 247.2% above the Chemicals median (#1265 of 1422)
No single metric tells the full story. See the IRLCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Israel Corp Ltd is a holding company. Along with its subsidiaries, it operates as a specialty minerals and chemicals company creating solutions to challenges in the food, agriculture, and industrial markets by leveraging its bromine, potash, and phosphate resources. The group operates through the following segments: Industrial Products (Bromine), Potash, Phosphate Solutions, and Growing Solutions. Maximum revenue is generated from its Phosphate Solutions segment, which manufactures phosphoric acid, sulphuric acid, green phosphoric acid, and phosphate fertilizers through its mines and facilities in Israel and China. Geographically, the group generates maximum revenue from Israel, followed by Europe, South America, North America, Asia, and other regions.
65GF Score
Get the complete analysis for IRLCF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRLCF has been successfully added to your 
